Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration
Y. Xie, S. Tolmeijer, J. Oskam, T. Tonkens, A. H. Meijer, M. J. M. Schaaf
Abstract
Glucocorticoid drugs are widely used to treat immune-related diseases, but their use is limited by side effects and by resistance, which especially occurs in macrophage-dominated diseases. In order to improve glucocorticoid therapies, more research is required into the mechanisms of glucocorticoid action. In the present study, we have used a zebrafish model for inflammation to study glucocorticoid effects on the innate immune response. In zebrafish larvae, the migration of neutrophils towards a site of injury is inhibited by the synthetic glucocorticoid beclomethasone, while migration of macrophages is glucocorticoid resistant. We show that wounding-induced increases in expression of genes encoding neutrophil-specific chemoattractants (Il8 and Cxcl18b) are attenuated by beclomethasone, but that beclomethasone does not attenuate the induction of the genes encoding Ccl2 and Cxcl11aa, which we show to be required for macrophage recruitment. RNA sequencing on Fluorescence-Activated Cell Sorting (FACS)-sorted macrophages showed that the vast majority of the wounding-induced transcriptional changes in these cells are inhibited by beclomethasone, whereas a small subset is glucocorticoid-insensitive. As a result, beclomethasone decreases the number of macrophages that differentiate towards a pro-inflammatory (M1) phenotype, which we demonstrated using a tnfa:eGFP-F reporter line and analysis of macrophage morphology. We conclude that the glucocorticoid resistance of the wounding-induced macrophage migration is due to the insensitivity of the induction of macrophage-specific chemoattractants to glucocorticoid inhibition, which may explain the relative resistance of macrophage-dominated diseases to glucocorticoid therapy. However, the induction of pro-inflammatory genes in macrophages is strongly attenuated, which inhibits their differentiation to an M1 phenotype.\n\nSummary statementIn a zebrafish model for inflammation, glucocorticoids do not affect the migration of macrophages, but inhibit differentiation towards an M1 phenotype, by strongly attenuating transcriptional responses in these cells.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Glucocorticoid treatment exacerbates mycobacterial infection by reducing the phagocytic capacity of macrophages
Y. Xie, A. H. Meijer, M. Schaaf·bioRxiv·Jun 19, 2020
- The glucocorticoid dexamethasone inhibits HIF-1alpha stabilisation and metabolic reprogramming in lipopolysaccharide-stimulated primary macrophages.
S. A. Clayton, C. Lockwood, … A. R. Clark·bioRxiv·Sep 20, 2023
- Inflammation reshapes epidermal and leukocyte differentiation resulting in altered glucocorticoid responsiveness
Erin Faught, Thomas Schrauwen, … Marcel Schaaf·bioRxiv·Oct 30, 2026
- AMPKα1 is essential for Glucocorticoid Receptor triggered anti-inflammatory macrophage activation
G. Caratti, T. Desgeorges, … R. Mounier·bioRxiv·Jan 2, 2020
- Glucocorticoids suppress NF-κB-mediated neutrophil control of Aspergillus fumigatus hyphal growth
Savini U. Thrikawala, Molly H. Anderson, Emily E. Rosowski·The Journal of ImmunologyPeer-reviewed·Aug 23, 2024
- The glucocorticoid dexamethasone impairs the expression of anti-viral mediators in activated macrophages by inhibiting both expression and function of interferon beta.
J. D. O'Neil, O. O. Bolimowska, … A. R. Clark·bioRxiv·May 3, 2023